ALLIENT INC quarterly report, Q2 FY2020

Allied Motion Technologies Inc. (AMOT) — Q2 2020 Form 10-Q

Filing identity: The filing names the issuer as Allied Motion Technologies Inc. Reporting period ended June 30, 2020; comparisons are against 2019. Amounts below are USD millions unless noted. The company designs and manufactures controlled-motion products and systems for vehicle, medical, aerospace and defense, and industrial markets.

Financial performance

MetricQ2 2020Q2 2019Six months 2020Six months 2019
Revenue$86.7$92.6$179.0$186.5
Gross profit / margin$26.5 / 30.5%$28.4 / 30.7%$54.5 / 30.4%$56.1 / 30.1%
Operating income$5.1$7.6$11.8$14.9
Net income$2.9$4.4$6.9$8.9
Diluted EPS$0.30$0.47$0.73$0.95
Operating cash flowNot provided by quarter$6.6$8.9

Q2 revenue fell 6% year over year and net income fell 35%; first-half revenue declined 4% and net income declined 22%. Q2 operating margin was approximately 5.8%, versus 8.2% a year earlier. First-half gross margin improved modestly, but operating income declined as operating expenses rose. Q2 bookings were $80.4 million, down 16%; backlog was $127.7 million, down 4% from the comparable prior-year date.

Revenue mix shifted sharply: Q2 vehicle revenue declined to $18.6 million from $30.8 million, while medical revenue rose to $24.3 million from $12.2 million, including the Dynamic Controls acquisition. For the first half, vehicle revenue was $46.6 million versus $64.4 million; medical revenue was $38.8 million versus $24.6 million.

Cash, debt and liquidity

  • Cash and equivalents were $19.0 million at June 30, up from $13.4 million at year-end 2019. Current assets were $133.8 million and current liabilities $49.7 million.
  • Long-term debt, net of issuance costs, was $128.5 million; gross revolver borrowings were $129.1 million. Approximate net debt after cash was $110.1 million.
  • The amended revolving facility totals $225 million and matures in February 2025; $95.9 million was unused at quarter-end. The company reported compliance with its financial covenants.
  • First-half operating cash flow was $6.6 million. Investing cash outflow was $18.3 million, including $14.7 million for the Dynamic Controls acquisition and $3.6 million of capital expenditures. Financing provided $17.3 million, primarily reflecting revolver borrowing.

Material changes, outlook and risks

  • COVID-19: Management attributed weaker demand, especially in Vehicle, to pandemic-related disruption. Supplier and facility interruptions and customer production reductions also affected operations. Management expected uncertainty to continue to weigh on demand in Q3 and beyond; no specific revenue or earnings guidance was provided.
  • Acquisition: Allied Motion acquired Dynamic Controls on March 7, 2020, expanding its medical-market and electronics/software capabilities. The preliminary purchase-price allocation included $6.6 million of goodwill and $7.8 million of identifiable intangible assets; goodwill is not tax deductible. Dynamic Controls contributed $9.9 million of Q2 revenue and $1.0 million of Q2 earnings. Acquisition-related costs were $0.2 million in Q2 and $0.4 million for the first half.
  • Management said cash, borrowing availability and anticipated operating cash flows should cover ordinary-course needs for the next 12 months. The company was controlling discretionary spending, aligning variable costs with demand, freezing hiring and wages, and maintaining key engineering capabilities.
  • Expected 2020 capital expenditures remained $10–12 million. Management also cited acquisition integration, customer and supplier conditions, foreign exchange, and the pandemic’s uncertain duration and effects as risks.
  • Interest-rate swaps hedged $60 million of revolver borrowings. The filing estimated a 100-basis-point rate change would affect first-half interest expense by about $0.35 million. A single customer represented 11% of Q2 revenue and 15% of receivables at quarter-end.

Important facts for investors to verify

  • Whether vehicle-market demand, bookings and backlog recover after pandemic-related disruption, and whether medical-market growth offsets weakness elsewhere.
  • Dynamic Controls’ ongoing contribution, final purchase-price allocation and realization of anticipated integration benefits.
  • Cash conversion and working-capital trends, particularly the first-half inventory increase, alongside debt levels and covenant headroom.
  • Progress against the $10–12 million 2020 capital expenditure expectation and management’s stated 12-month liquidity assessment.
  • Customer concentration and sensitivity to foreign-exchange and interest-rate movements.